Acceleron Pharma

http://www.acceleronpharma.com/

+1-617-649-92-00

128 Sidney Street Cambridge

USA

Acceleron Pharma Inc

128 Sidney Street

John Knopf, Ph.D., CEO and Founder
Kevin McLaughlin, Chief Financial Officer
Matthew L. Sherman, M.D., Chief Medical Officer
Steven Ertel, Chief Business Officer
Ravi Kumar, Ph.D., Chief Scientific Officer
Robert Steininger, SVP, Manufacturing
John Quisel, J.D., Ph.D., VP and General Counsel
Nancy Sullivan, VP, Operations
Kenneth Attie, M.D., VP, Medical Research
James Desiderio, Ph.D., VP, Regulatory Affairs
Melissa Morandi, VP, Quality
Douglas W. Pagan, VP, Finance
Christopher Rovaldi, VP, Program Management

Production

Rheumatoid arthritis, Blood cancer

John Knopf, Ph.D., CEO, Acceleron
Anthony B. Evnin, Ph.D., Venrock Associates
Jean George, Advanced Technology Ventures
George Golumbeski, Ph.D., Celgene
Carl L. Gordon, Ph.D., CFA, OrbiMed Advisors
Edwin M. Kania, Jr., Flagship Ventures
Terrance G. McGuire, Polaris Venture Partners
Tom Maniatis, Ph.D., Columbia University
Richard F. Pops, Alkermes
Joseph S. Zakrzewski, Amarin
Wylie W. Vale, Ph.D. (in memoriam), Salk Institute

Other, Pharmaceuticals